A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues
- Author
- BRIGGS, C. A1 ; SCHRIMPF, M. R1 ; BUNNELLE, W. H1 ; GOPALAKRISHNAN, M1 ; MEYER, M. D1 ; ANDERSON, D. J1 ; GUBBINS, E. J1 ; GRONLIEN, J. H1 ; HAKERUD, M1 ; WEEN, H1 ; THORIN-HAGENE, K1 ; MALYSZ, J1 ; LI, J1
[1] Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL, United States - Source
British journal of pharmacology. 2008, Vol 153, Num 5, pp 1054-1061, 8 p ; ref : 1 p.1/4
- CODEN
- BJPCBM
- ISSN
- 0007-1188
- Scientific domain
- Pharmacology drugs
- Publisher
- Nature Publishing, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Xenopus oocytes cognition nicotinic acetylcholine receptor tilorone α7 nicotinic receptor
- Keyword (fr)
- Agoniste Antiviral Cognition Composé tricyclique In vitro Récepteur cholinergique Récepteur nicotinique α7 Récepteur nicotinique Tilorone Xenopus laevis Amphibia Salientia Vertebrata
- Keyword (en)
- Agonist Antiviral Cognition Tricyclic compound In vitro Cholinergic receptor α7 nicotinic receptor Nicotinic receptor Tilorone Xenopus laevis Amphibia Salientia Vertebrata
- Keyword (es)
- Agonista Antiviral Cognición Compuesto tricíclico In vitro Receptor colinérgico Receptor nicotínico α7 Receptor nicotínico Tilorona Xenopus laevis Amphibia Salientia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20178637
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.bjp.0707649 
https://dx.doi.org/10.1038/sj.bjp.0707649
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:9:\"\u0000*\u0000jtitle\";s:31:\"British journal of pharmacology\";s:9:\"\u0000*\u0000stitle\";s:16:\"Br. j. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"153\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1054\";s:8:\"\u0000*\u0000epage\";s:4:\"1061\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1188\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BRIGGS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SCHRIMPF, M. R\";i:1;s:14:\"BUNNELLE, W. H\";i:2;s:17:\"GOPALAKRISHNAN, M\";i:3;s:11:\"MEYER, M. D\";i:4;s:14:\"ANDERSON, D. J\";i:5;s:13:\"GUBBINS, E. J\";i:6;s:14:\"GRONLIEN, J. H\";i:7;s:10:\"HAKERUD, M\";i:8;s:7:\"WEEN, H\";i:9;s:16:\"THORIN-HAGENE, K\";i:10;s:9:\"MALYSZ, J\";i:11;s:5:\"LI, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJPCBM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:9:\"\u0000*\u0000jtitle\";s:31:\"British journal of pharmacology\";s:9:\"\u0000*\u0000stitle\";s:16:\"Br. j. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"153\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1054\";s:8:\"\u0000*\u0000epage\";s:4:\"1061\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1188\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BRIGGS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SCHRIMPF, M. R\";i:1;s:14:\"BUNNELLE, W. H\";i:2;s:17:\"GOPALAKRISHNAN, M\";i:3;s:11:\"MEYER, M. D\";i:4;s:14:\"ANDERSON, D. J\";i:5;s:13:\"GUBBINS, E. J\";i:6;s:14:\"GRONLIEN, J. H\";i:7;s:10:\"HAKERUD, M\";i:8;s:7:\"WEEN, H\";i:9;s:16:\"THORIN-HAGENE, K\";i:10;s:9:\"MALYSZ, J\";i:11;s:5:\"LI, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJPCBM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:9:\"\u0000*\u0000jtitle\";s:31:\"British journal of pharmacology\";s:9:\"\u0000*\u0000stitle\";s:16:\"Br. j. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"153\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1054\";s:8:\"\u0000*\u0000epage\";s:4:\"1061\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1188\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BRIGGS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SCHRIMPF, M. R\";i:1;s:14:\"BUNNELLE, W. H\";i:2;s:17:\"GOPALAKRISHNAN, M\";i:3;s:11:\"MEYER, M. D\";i:4;s:14:\"ANDERSON, D. J\";i:5;s:13:\"GUBBINS, E. J\";i:6;s:14:\"GRONLIEN, J. H\";i:7;s:10:\"HAKERUD, M\";i:8;s:7:\"WEEN, H\";i:9;s:16:\"THORIN-HAGENE, K\";i:10;s:9:\"MALYSZ, J\";i:11;s:5:\"LI, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJPCBM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:9:\"\u0000*\u0000jtitle\";s:31:\"British journal of pharmacology\";s:9:\"\u0000*\u0000stitle\";s:16:\"Br. j. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"153\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1054\";s:8:\"\u0000*\u0000epage\";s:4:\"1061\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1188\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BRIGGS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SCHRIMPF, M. R\";i:1;s:14:\"BUNNELLE, W. H\";i:2;s:17:\"GOPALAKRISHNAN, M\";i:3;s:11:\"MEYER, M. D\";i:4;s:14:\"ANDERSON, D. J\";i:5;s:13:\"GUBBINS, E. J\";i:6;s:14:\"GRONLIEN, J. H\";i:7;s:10:\"HAKERUD, M\";i:8;s:7:\"WEEN, H\";i:9;s:16:\"THORIN-HAGENE, K\";i:10;s:9:\"MALYSZ, J\";i:11;s:5:\"LI, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJPCBM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjp.0707649\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:9:\"\u0000*\u0000jtitle\";s:31:\"British journal of pharmacology\";s:9:\"\u0000*\u0000stitle\";s:16:\"Br. j. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"153\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1054\";s:8:\"\u0000*\u0000epage\";s:4:\"1061\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1188\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"BRIGGS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"SCHRIMPF, M. R\";i:1;s:14:\"BUNNELLE, W. H\";i:2;s:17:\"GOPALAKRISHNAN, M\";i:3;s:11:\"MEYER, M. D\";i:4;s:14:\"ANDERSON, D. J\";i:5;s:13:\"GUBBINS, E. J\";i:6;s:14:\"GRONLIEN, J. H\";i:7;s:10:\"HAKERUD, M\";i:8;s:7:\"WEEN, H\";i:9;s:16:\"THORIN-HAGENE, K\";i:10;s:9:\"MALYSZ, J\";i:11;s:5:\"LI, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJPCBM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
